Distinguishing Mixed Connective Tissue Disease from Systemic Lupus Erythematosus
Serological Distinction
- High-titer anti-U1-RNP antibodies are mandatory for Mixed Connective Tissue Disease diagnosis and typically produce a coarse speckled ANA pattern, according to the American College of Rheumatology 1, 2
Clinical Features That Favor MCTD Over SLE
- Interstitial lung disease occurs in 40-80% of MCTD patients, with NSIP pattern being most common, as reported by the European Respiratory Society 2, 3
- Pulmonary hypertension is a major cause of mortality in MCTD, affecting up to 38% of patients, according to the American Thoracic Society 2
Diagnostic Algorithm
- The American College of Rheumatology recommends that high-titer anti-U1-RNP is required for MCTD consideration, with determination of antibody serotype and testing for 70 kDa specificity 1, 2
Monitoring Recommendations for MCTD
- The European Respiratory Society recommends pulmonary function tests every 6 months for patients with systemic sclerosis phenotype 2
- Annual HRCT for the first 3-4 years after diagnosis is recommended by the American College of Rheumatology 2
- Screening for pulmonary hypertension is advised given its high prevalence and mortality impact, as suggested by the American Heart Association 2
Distinguishing MCTD from SLE
Serological Distinction
- The American College of Rheumatology suggests that anti-dsDNA and anti-Sm antibodies favor SLE over MCTD, with a distinction based on the presence of high-titer anti-U1-RNP antibodies in MCTD 4
- The European League Against Rheumatism notes that ANA pattern differences, with MCTD showing a coarse speckled pattern and SLE typically showing a homogeneous pattern, can aid in diagnosis 5
Diagnostic Algorithm
- The American College of Rheumatology recommends checking ANA pattern and titer, with a coarse speckled pattern suggesting MCTD and a homogeneous pattern suggesting SLE, as an initial step in diagnosis 5